Cellular senescence by loss of Men1 in osteoblasts is critical for age‐related osteoporosis

Yuichiro Ukon,Takashi Kaito,Hiromasa Hirai,Takayuki Kitahara,Masayuki Bun,Joe Kodama,Daisuke Tateiwa,Shinichi Nakagawa,Masato Ikuta,Takuya Furuichi,Yuya Kanie,Takahito Fujimori,Shota Takenaka,Tadashi Yamamuro,Satoru Otsuru,Seiji Okada,Masakatsu Yamashita,Takeshi Imamura
DOI: https://doi.org/10.1111/acel.14254
IF: 11.005
2024-06-23
Aging Cell
Abstract:Osteoblast‐specific inducible Men1 knockout mimics age‐related osteoporosis even in young mice. Men1 deletion in osteoblasts promotes replicative stress‐induced cellular senescence presumably through mTORC1 activation and AMPK suppression, rescued by metformin treatment. Recent evidence suggests an association between age‐related osteoporosis and cellular senescence in the bone; however, the specific bone cells that play a critical role in age‐related osteoporosis and the mechanism remain unknown. Results revealed that age‐related osteoporosis is characterized by the loss of osteoblast Men1. Osteoblast‐specific inducible knockout of Men1 caused structural changes in the mice bones, matching the phenotypes in patients with age‐related osteoporosis. Histomorphometrically, Men1‐knockout mice femurs decreased osteoblastic activity and increased osteoclastic activity, hallmarks of age‐related osteoporosis. Loss of Men1 induces cellular senescence via mTORC1 activation and AMPK suppression, rescued by metformin treatment. In bone morphogenetic protein‐indued bone model, loss of Men1 leads to accumulation of senescent cells and osteoporotic bone formation, which are ameliorated by metformin. Our results indicate that cellular senescence in osteoblasts plays a critical role in age‐related osteoporosis and that osteoblast‐specific inducible Men1‐knockout mice offer a promising model for developing therapeutics for age‐related osteoporosis.
cell biology,geriatrics & gerontology
What problem does this paper attempt to address?